These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 38236305)

  • 1. Glial cell alterations in diabetes-induced neurodegeneration.
    Llorián-Salvador M; Cabeza-Fernández S; Gomez-Sanchez JA; de la Fuente AG
    Cell Mol Life Sci; 2024 Jan; 81(1):47. PubMed ID: 38236305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Inflammation in Diabetic Retinopathy.
    Rübsam A; Parikh S; Fort PE
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29565290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted pharmacotherapy against neurodegeneration and neuroinflammation in early diabetic retinopathy.
    Rolev KD; Shu XS; Ying Y
    Neuropharmacology; 2021 Apr; 187():108498. PubMed ID: 33582150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes-Related Neurological Implications and Pharmacogenomics.
    Rojas-Carranza CA; Bustos-Cruz RH; Pino-Pinzon CJ; Ariza-Marquez YV; Gomez-Bello RM; Canadas-Garre M
    Curr Pharm Des; 2018; 24(15):1695-1710. PubMed ID: 28322157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Modified Curcumin Preparations on Glial Morphology in Aging and Neuroinflammation.
    Ullah F; Gamage R; Sen MK; Gyengesi E
    Neurochem Res; 2022 Apr; 47(4):813-824. PubMed ID: 34988899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioengineered 3D Glial Cell Culture Systems and Applications for Neurodegeneration and Neuroinflammation.
    Watson PMD; Kavanagh E; Allenby G; Vassey M
    SLAS Discov; 2017 Jun; 22(5):583-601. PubMed ID: 28346104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidating glial responses to products of diabetes-associated systemic dyshomeostasis.
    Padovani-Claudio DA; Ramos CJ; Capozzi ME; Penn JS
    Prog Retin Eye Res; 2023 May; 94():101151. PubMed ID: 37028118
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Majimbi M; McLenachan S; Nesbit M; Chen FK; Lam V; Mamo J; Takechi R
    Front Endocrinol (Lausanne); 2023; 14():1224418. PubMed ID: 37850093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial reactivity, an early feature of diabetic retinopathy.
    Rungger-Brändle E; Dosso AA; Leuenberger PM
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1971-80. PubMed ID: 10845624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100B as a glial cell marker in diabetic peripheral neuropathy.
    Celikbilek A; Akyol L; Sabah S; Tanik N; Adam M; Celikbilek M; Korkmaz M; Yilmaz N
    Neurosci Lett; 2014 Jan; 558():53-7. PubMed ID: 24211224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of glial cells in the homeostasis of the retinal microenvironment and their pivotal role in the course of diabetic retinopathy.
    Sorrentino FS; Allkabes M; Salsini G; Bonifazzi C; Perri P
    Life Sci; 2016 Oct; 162():54-9. PubMed ID: 27497914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIP3-mediated microglial necroptosis promotes neuroinflammation and neurodegeneration in the early stages of diabetic retinopathy.
    Huang Z; Liang J; Chen S; Ng TK; Brelén ME; Liu Q; Yang R; Xie B; Ke S; Chen W; Huang D
    Cell Death Dis; 2023 Mar; 14(3):227. PubMed ID: 36991017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of glial metabolic dysregulation in the pathophysiology of neurodegenerative diseases.
    Afridi R; Rahman MH; Suk K
    Neurobiol Dis; 2022 Nov; 174():105874. PubMed ID: 36154877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional polarization of neuroglia: Implications in neuroinflammation and neurological disorders.
    Jha MK; Lee WH; Suk K
    Biochem Pharmacol; 2016 Mar; 103():1-16. PubMed ID: 26556658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes.
    Lee VK; Hosking BM; Holeniewska J; Kubala EC; Lundh von Leithner P; Gardner PJ; Foxton RH; Shima DT
    Diabetologia; 2018 Nov; 61(11):2422-2432. PubMed ID: 30094465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group.
    Lieth E; Barber AJ; Xu B; Dice C; Ratz MJ; Tanase D; Strother JM
    Diabetes; 1998 May; 47(5):815-20. PubMed ID: 9588455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic control of early neurodegenerative events in diabetic retinopathy by the histone deacetylase SIRT6.
    Zorrilla-Zubilete MA; Yeste A; Quintana FJ; Toiber D; Mostoslavsky R; Silberman DM
    J Neurochem; 2018 Jan; 144(2):128-138. PubMed ID: 29049850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinflammation Involved in Diabetes-Related Pain and Itch.
    Fang XX; Wang H; Song HL; Wang J; Zhang ZJ
    Front Pharmacol; 2022; 13():921612. PubMed ID: 35795572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence supporting a role for N-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Müller glia dysfunction and death in diabetic retinopathy.
    Yong PH; Zong H; Medina RJ; Limb GA; Uchida K; Stitt AW; Curtis TM
    Mol Vis; 2010 Dec; 16():2524-38. PubMed ID: 21151599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1β is upregulated in the diabetic retina and retinal vessels: cell-specific effect of high glucose and IL-1β autostimulation.
    Liu Y; Biarnés Costa M; Gerhardinger C
    PLoS One; 2012; 7(5):e36949. PubMed ID: 22615852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.